Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 14, 2022 07:30 ET | Source: GT Biopharma, Inc.

GT Biopharma Names Dr. Jeff Miller as Consulting Chief Medical Officer

BRISBANE, CALIFORNIA, Dec. 14, 2022 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (the “Company” or “GTB”) (NASDAQ: GTBP), a clinical stage immuno-oncology company focused on developing innovative...
October 31, 2022 17:15 ET | Source: GT Biopharma, Inc.

GT Biopharma Reports Third Quarter Fiscal 2022 Financial Results and Business Update

Announced two poster presentations at the Society for Immunotherapy of Cancer’s 37th Annual Meeting (SITC 2022)$20.8 million in cash, cash equivalents and short-term investments as of September 30,...
January 05, 2021 01:00 ET | Source: INNATE PHARMA

Un premier anticorps multispécifique engageant les cellules NK d'Innate sélectionné par Sanofi comme candidat-médicament

Marseille, 05 janv. 2021 (GLOBE NEWSWIRE) -- IPH6101/SAR443579 est un anticorps multispécifique engageant les cellules NK (NKCE) via leur récepteur activateur NKp46 et utilisant le format...
January 05, 2021 01:00 ET | Source: INNATE PHARMA

Innate's first NK cell engager selected by Sanofi as drug candidate for development

Marseille, Jan. 05, 2021 (GLOBE NEWSWIRE) -- IPH6101/SAR443579 is an NKp46-based NK cell engager (NKCE) that uses Innate’s proprietary multispecific antibody formatSelection of IPH6101/SAR443579...